Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 16 Feb 2021
  • Report ID: HLT 00131
  • Pages:180
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the global mantle cell lymphoma market is estimated to grow at a CAGR of 7.3% during the forecast period. Mantle cell lymphoma (MCL) is a type of blood cancer that affects white blood cells called lymphocytes. Lymphocytes are white blood cells that help fight infections and other diseases in the body. The disease got its name as it affects lymphocytes in the mantle zone of a lymph node. MCL cells can affect other lymph nodes or tissues, such as the liver, gastrointestinal tract, and marrow. It occurs more commonly in men than in women. Caucasian men and women are prone to higher risk than men and women of color. MCL occurs mostly in the geriatric population and the average age when cases are diagnosed in the mid-60s. Some of the common symptoms of the disease include abdominal pain or bloating, fever, loss of appetite & weight loss, discomfort, nausea and vomiting, night sweats, and indigestion. The type of treatment for a patient suffering from MCL depends on several factors such as age, the current health of the patient, and the disease stage.

Top Driver: Rising Prevalence of Mantle Cell Lymphoma and Developing R & d Activities

The major driving factors for the growth of global mantle cell lymphoma include the rising prevalence of mantle cell lymphoma and growing research & development activities in the healthcare sector, leading to a robust product pipeline. For instance, according to the reports of Drug Development Technology, 2017, an estimated 3,300 new cases of MCL are diagnosed every year in the US. The presence of a rising number of research and development activities is estimated to drive the market. For instance, according to the article published on October 9, 2019, according to Simon Rule, we are focusing on therapeutic approaches in the frontline setting of Mantle Cell Lymphoma (MCL). He described that the BTK inhibitors could take over the upfront space and potentially combine, and chemotherapy will be an upcoming action. According to an article published on May 9, 2019, a study by the University of Texas and MD Anderson Cancer Center illustrated that a small molecule drug, named IACS-10759, might help overcome ibrutinib resistance in mantle cell lymphoma.

The Targeted Therapy Segment is Anticipated to Witness Growth During the Forecast Period

The global mantle cell lymphoma market has been segmented into chemotherapy, targeted therapy, radiotherapy, and others by therapy type. Among these, the targeted therapy segment is estimated to grow at a significant rate during the forecast period. The emergence of the targeted agents with low toxicity profiles to treat relapsed mantle cell lymphoma (MCL) coupled with approved drugs is a key factor augmenting the mantle cell lymphoma treatment market growth. On the basis of application, the market is segmented into hospital, research institute and others.

 Increasing in the Prevalence of MCL and Growth in Health Care awareness to Benefit North America Market

North America is estimated to lead the global mantle cell lymphoma treatment market during the forecast period. The growth is attributed to an increasing in the prevalence of mantle cell lymphomas and growth in health care awareness among the population about early diagnosis. The FDA is also focusing on rare diseases, such as mantle cell lymphoma, by granting maximum approvals, breakthrough designations, and orphan drug designations to make treatments available for patients with rare diseases. Following North America, the Asia Pacific and Europe are estimated to be the other major markets due to the rise in government initiatives and the rise in research and development activities.

Players to Focus on Research and Development   

The global Mantle cell lymphoma market is anticipated to stay fragmented due to the new entrants. Major key players operating in the market include Bristol-Myers Squibb, GlaxoSmithKline plc, Amgen, Inc., Celgene Corporation, Eli Lilly and Company, AbbVie, Inc., F. Hoffmann-La Roche AG, Bayer AG, Kite Pharma (Gilead Sciences, Inc.), and Johnson & Johnson

Eli Lilly and Company: In November 6, 2019, Eli Lilly and Company declared that multiple abstracts from the LOXO-305 program had been accepted for the presentation at the 61st American Society of Hematology Annual Meeting and Exposition to be held in December 7-10, 2019 in Orlando, Florida. LOXO-305 is a next-generation, highly selective, non-covalent BTK inhibitor.

Scope of the Report

By Therapy Type 

  • Chemotherapy
  • Targeted therapy
  • Radiotherapy
  • Others

By Application

  • Hospital
  • Research Institutes
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1          Overview And Scope

1.1            Market Vision

1.1.1        Market Definition

1.1.2        Market Scope

1.2            Market Segmentation

Chapter 2          Our Research Practice

2.1            Our Research Methodology

2.2            Data Triangulation

2.3            Data Sources

2.4            Assumptions for the study

2.5            Approach Adopted

Chapter 3          Executive Summary

3.1            Market Snapshot

3.2            Regional Snapshot

3.3            Segment Summary

Chapter 4          Covid-19 Impact Analysis

4.1            Overview

4.2            Prevalence analysis

4.3            Key Factor Impact Analysis

Chapter 5          Global Sleep Apnea Devices Market Forces

5.1            What’s Driving the Market

5.2            Porter’s Five Forces Analysis

5.2.1        Power of Suppliers

5.2.2        Threats From New Entrants

5.2.3        Power of Buyer

5.2.4        Threat From Substitute Product

5.2.5        Degree of Competition

Chapter 6          Global Sleep Apnea Devices Market -Industry Snapshots

6.1            Overview

6.1.1        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

6.2            Market Overview

6.2.1        Drivers Analysis

6.2.2        Restraint/Challenges analysis

6.2.3        Opportunity Analysis

6.3            Supply Chain/Value Chain Analysis

6.4            Market SWOT Analysis

Chapter 7          Global Sleep Apnea Devices Market Analysis, by Diagnostic Devices

7.1            Overview

7.2            Key Findings for Sleep Apnea Devices Market- By Diagnostic Devices

7.2.1        Sleep Apnea Devices Market- Pulse oximeters

7.2.2        Sleep Apnea Devices Market- Actigraphy devices

7.2.3        Sleep Apnea Devices Market- Polysomnography Devices

Chapter 8          Global Sleep Apnea Devices Market Analysis, by Therapeutic Devices

8.1            Overview

8.2            Key Findings for Sleep Apnea Devices Market- By Therapeutic Devices

8.2.1        Sleep Apnea Devices Market- Oxygen Devices

8.2.2        Sleep Apnea Devices Market- Positive Airways Pressure Devices

8.2.3        Sleep Apnea Devices Market- Oral Appliances

8.2.4        Sleep Apnea Devices Market- Others

Chapter 9          Sleep Apnea Devices Market Analysis by Region

9.1            Key Findings for Sleep Apnea Devices Market- By region

9.2            Overview

9.2.1        Global Sleep Apnea Devices Market Analysis, By Diagnostic Devices, 2019 – 2028

9.2.2        Global Sleep Apnea Devices Market Analysis, By Therapeutic Devices, 2019 – 2028

9.3            Sleep Apnea Devices Market – North America

9.3.1        Overview

9.3.2        U.S.

9.3.3        Canada

9.3.4        Mexico

9.3.5        North America Market, By Diagnostic Devices

9.3.6        North America Market, By Therapeutic Devices

9.4            Sleep Apnea Devices Market – Europe

9.4.1        Overview

9.4.2        Germany

9.4.3        United Kingdom

9.4.4        France

9.4.5        Italy

9.4.6        Rest Of Europe

9.4.7        Europe Market, By Diagnostic Devices

9.4.8        Europe Market, By Therapeutic Devices

9.5            Sleep Apnea Devices Market – Asia Pacific

9.5.1        Overview

9.5.2        China

9.5.3        Japan

9.5.4        India

9.5.5        Rest of APAC

9.5.6        Asia Pacific Market, By Diagnostic Devices

9.5.7        Asia Pacific Market, By Therapeutic Devices

9.6            Sleep Apnea Devices Market – SAMEA

9.6.1        Overview

9.6.2        Middle East & Africa (MEA)

9.6.3        South America

9.6.4        Rest Of World

9.6.5        South America, Middle East and Africa Market, By Diagnostic Devices

9.6.6        South America, Middle East and Africa Market, By Therapeutic Devices

Chapter 10      Market Competition Analysis

10.1          Market Share/Positioning Analysis

10.1.1      Market Positioning of Key Vendors, 2019

10.1.2      Key Strategies Adopted by the Leading Players

10.1.3      Recent Developments

Chapter 11      Company Profiles- Snapshot

11.1          Curative Medical Inc

11.1.1      Business Fundamentals

11.1.2      Financial Snapshots

11.1.3      Product Portfolio

11.1.4      Recent Developments

11.2          Philips Respironics

11.3          ResMed

11.4          Fisher & Paykel Healthcare

11.5          Cadwell Laboratories

11.6          Invacare Corporation

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 12      Appendix

List of Figures

 

FIG. 1          Global Sleep Apnea Devices: Market Segmentation

FIG. 2          Global Sleep Apnea Devices Market: Research Methodology

FIG. 3          Top-Down and Bottom Up Approach

FIG. 4          Market Snapshot

FIG. 5          Porter’s Five Forces Analysis

FIG. 6          Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 7          Supply Chain/Value Chain Analysis

FIG. 8          Global Sleep Apnea Devices Market Value Contribution, By Diagnostic Devices, 2019 & 2026 (%)

FIG. 9          Global Sleep Apnea Devices Market Value Contribution, By Therapeutic Devices, 2019 & 2026 (%)

FIG. 10        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 11        North America Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 12        Sleep Apnea Devices Market Segment 1 – North America

FIG. 13        Sleep Apnea Devices Market Segment 2 – North America

FIG. 14        Sleep Apnea Devices U.S. outlook, 2019 & 2026

FIG. 15        Sleep Apnea Devices Canada outlook, 2019 & 2026

FIG. 16        Sleep Apnea Devices Mexico outlook, 2019 & 2026

FIG. 17        Europe Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 18        Sleep Apnea Devices Market Segment 1 – Europe

FIG. 19        Sleep Apnea Devices Market Segment 2 – Europe

FIG. 20        Sleep Apnea Devices Germany outlook, 2019 & 2026

FIG. 21        Sleep Apnea Devices United Kingdom outlook, 2019 & 2026

FIG. 22        Sleep Apnea Devices France outlook, 2019 & 2026

FIG. 23        Sleep Apnea Devices Italy outlook, 2019 & 2026

FIG. 24        Sleep Apnea Devices Rest Of Europe outlook, 2019 & 2026

FIG. 25        Asia Pacific Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 26        Sleep Apnea Devices Market Segment 1 – Asia Pacific

FIG. 27        Sleep Apnea Devices Market Segment 2 – Asia Pacific

FIG. 28        Sleep Apnea Devices China outlook, 2019 & 2026

FIG. 29        Sleep Apnea Devices Japan outlook, 2019 & 2026

FIG. 30        Sleep Apnea Devices India outlook, 2019 & 2026

FIG. 31        Sleep Apnea Devices Rest of APAC outlook, 2019 & 2026

FIG. 32        SAMEA Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 33        Sleep Apnea Devices Market Segment 1 – SAMEA

FIG. 34        Sleep Apnea Devices Market Segment 2 – SAMEA

FIG. 35        Sleep Apnea Devices Middle East & Africa (MEA) outlook, 2019 & 2026

FIG. 36        Sleep Apnea Devices South America outlook, 2019 & 2026

FIG. 37        Sleep Apnea Devices Rest Of World outlook, 2019 & 2026

 

List of Tables

 

TABLE 1      Sleep Apnea Devices market by Diagnostic Devices 1, 2019 – 2028 (USD Million)

TABLE 2      Sleep Apnea Devices market by Diagnostic Devices 2, 2019 – 2028 (USD Million)

TABLE 3      Sleep Apnea Devices market by Diagnostic Devices 3, 2019 – 2028 (USD Million)

TABLE 4      Sleep Apnea Devices market by Therapeutic Devices 1, 2019 – 2028 (USD Million)

TABLE 5      Sleep Apnea Devices market by Therapeutic Devices 2, 2019 – 2028 (USD Million)

TABLE 6      Sleep Apnea Devices market by Therapeutic Devices 3, 2019 – 2028 (USD Million)

TABLE 7      Sleep Apnea Devices market by Therapeutic Devices 4, 2019 – 2028 (USD Million)

TABLE 8      Global Sleep Apnea Devices Market Value, By Diagnostic Devices, 2019 – 2028 (US$ Bn)

TABLE 9      Global Sleep Apnea Devices Market Value, By Therapeutic Devices, 2019 – 2028 (US$ Bn)

TABLE 10   Sleep Apnea Devices Market Analysis by North America (USD Million), 2019 – 2028

TABLE 11   U.S. Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 12   U.S. Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 13   U.S. Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 14   Canada Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 15   Canada Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 16   Canada Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 17   Mexico Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 18   Mexico Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 19   Mexico Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 20   Sleep Apnea Devices Market Analysis by Europe (USD Million), 2019 – 2028

TABLE 21   Germany Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 22   Germany Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 23   Germany Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 24   United Kingdom Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 25   United Kingdom Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 26   United Kingdom Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 27   France Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 28   France Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 29   France Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 30   Italy Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 31   Italy Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 32   Italy Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 33   Rest Of Europe Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 34   Rest Of Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 35   Rest Of Europe Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 36   Sleep Apnea Devices Market Analysis by Asia Pacific (USD Million), 2019 – 2028

TABLE 37   China Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 38   China Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 39   China Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 40   Japan Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 41   Japan Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 42   Japan Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 43   India Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 44   India Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 45   India Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 46   Rest of APAC Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 47   Rest of APAC Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 48   Rest of APAC Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 49   Sleep Apnea Devices Market Analysis by SAMEA (USD Million), 2019 – 2028

TABLE 50   Middle East & Africa (MEA) Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 51   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 52   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 53   South America Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 54   South America Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 55   South America Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 56   Rest Of World Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 57   Rest Of World Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 58   Rest Of World Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

Request for Sample

Please fill out the form to receive sample pages of the report